NCT00551447View on ClinicalTrials.gov

A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)

PHASE3CompletedINTERVENTIONAL

Enrollment

616

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions

Coronary Disease

Interventions

DRUG

MK0653, ezetimibe / Duration of Treatment: 27 Weeks

DRUG

MK0733, simvastatin / Duration of Treatment: 27 Weeks

DRUG

Comparator: simvastatin / Duration of Treatment: 27 Weeks

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00551447 - A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED) | Biotech Hunter | Biotech Hunter